Aperçu des produits pour anti-BCL2L1 (BCL2L1) Anticorps

Full name:: anti-BCL2-Like 1 Anticorps (BCL2L1)

Chez www.anticorps-enligne.fr sont 569 BCL2-Like 1 (BCL2L1) Anticorps de 38 de différents fournisseurs disponibles. De plus, nous expédions BCL2L1 Kits (24) et BCL2L1 Protéines (19) et beaucoup plus de produits pour cette protéine. Un total de 641 BCL2L1 produits sont actuellement listés.

Synonymes:: Bcl(X)L, bcl-X, bcl-x(l), bcl-xl, bcl-xl/s, bcl-xs, bcl2l, BCL2L1, bclx, bclxl, BCLXS, blp1, cb1021, PPP1R52, xR11, zfBLP1

afficher tous les anticorps	Gène	GeneID	UniProt
	BCL2L1	598	Q07817
	BCL2L1	12048	Q64373
	BCL2L1	24888	P53563
Afficher toutes les espèces Afficher tous les synonymes

Réactivités les plus populaires pour anti-BCL2L1 (BCL2L1) Anticorps

Sélectionnez vos espèces et l'application

anti-Human BCL2L1 Anticorps:

anti-Mouse (Murine) BCL2L1 Anticorps:

anti-Rat (Rattus) BCL2L1 Anticorps:

Tous anti-BCL2L1 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

Pathways pertinentes pour anti-BCL2L1 Anticorps

Plus produit pour BCL2L1 Anticorps

anti-BCL2L1 Anticorps mieux référencés

Human Polyclonal BCL2L1 Primary Antibody pour ELISA, IF (p) - ABIN675129 : Wang, Ma, Su: NF-?B pathway contributes to cadmium-induced apoptosis of porcine granulosa cells. dans Biological trace element research 2013 (PubMed)
Show all 6 Pubmed References
Human Polyclonal BCL2L1 Primary Antibody pour IP, WB - ABIN223050 : Cordiali-Fei, Ardigo, Mastroianni, Giuliani, D Agosto, Bordignon, Trento, Vento, Berardesca: Serum cytokines and biohumoral immunological characterization of psoriatic patients in long term etanercept treatment. dans International journal of immunopathology and pharmacology 2008 (PubMed)
Show all 3 Pubmed References
Human Polyclonal BCL2L1 Primary Antibody pour IHC - ABIN965653 : Cheng, Levine, Boise, Thompson, Hardwick: Bax-independent inhibition of apoptosis by Bcl-XL. dans Nature 1996 (PubMed)
Show all 3 Pubmed References
Human Monoclonal BCL2L1 Primary Antibody pour FACS - ABIN135024 : Chittenden, Harrington, OConnor, Flemington, Lutz, Evan, Guild: Induction of apoptosis by the Bcl-2 homologue Bak. dans Nature 1995 (PubMed)
Show all 8 Pubmed References
Human Polyclonal BCL2L1 Primary Antibody pour IF, IHC - ABIN4368418 : Liu, Huang, Zeng, Chen, Huang, Guo, Liu, Xu, Mo, Li: Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway. dans Journal of cancer research and clinical oncology 2011 (PubMed)
Human Monoclonal BCL2L1 Primary Antibody pour FACS, IHC - ABIN440456 : Punnoose, Leverson, Peale, Boghaert, Belmont, Tan, Young, Mitten, Ingalla, Darbonne, Oleksijew, Tapang, Yue, Oeh, Lee, Maiga, Fairbrother, Amiot, Souers, Sampath: Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models. dans Molecular cancer therapeutics 2016 (PubMed)
Human Monoclonal BCL2L1 Primary Antibody pour IF, PLA - ABIN560043 : Türkmen, Riehn, Klopocki, Molkentin, Reinhardt, Burmeister: A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1. dans Genes, chromosomes & cancer 2011 (PubMed)
Human Monoclonal BCL2L1 Primary Antibody pour FACS - ABIN135023 : Rajah, Bhala, Nunn, Peehl, Cohen: 7S nerve growth factor is an insulin-like growth factor-binding protein protease. dans Endocrinology 1996 (PubMed)
Show all 7 Pubmed References
Human Monoclonal BCL2L1 Primary Antibody pour FACS - ABIN135021 : Kiefer, Brauer, Powers, Wu, Umansky, Tomei, Barr: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. dans Nature 1995 (PubMed)
Show all 7 Pubmed References

Plus d’anticorps contre BCL2L1 partenaires d’interaction

Human BCL2-Like 1 (BCL2L1) interaction partners

BCL-XL promotes stemness and contributes to the aggressiveness of both melanoma and glioblastoma.
inhibition of the BCL2 family member BCLxL resulted in nanomolar potency against human synovial sarcoma cell lines and 50% tumor reduction in a genetically engineered mouse model
In this study, we investigated whether APG (Montrer SMAD1 Anticorps)-1252-12A inhibits the growth of five leukemia cell lines in a concentration- or time-dependent manner by MTS (Montrer TIMM8A Anticorps) assay.APG-1252-12A is a Bcl-2 (Montrer BCL2 Anticorps) homology (BH)-3 mimetic that specifically binds to Bcl-2 (Montrer BCL2 Anticorps) and Bcl-xl, which has shown efficacy in some Bcl-2 (Montrer BCL2 Anticorps) dependent hematological cancers
inhibition of Bcl-xL induces significantly more apoptosis in IDH1 (Montrer IDH1 Anticorps)-mutated cells than in wild-type IDH1 (Montrer IDH1 Anticorps) cells.
CCAT1 is upregulated in docetaxel-resistant lung adenocarcinoma cells; its oncogenic function depends on sponging of let-7c, which releases Bcl-xl, promoting the acquisition of chemoresistance and epithelial-to-mesenchymal transition phenotypes
In the epithelial ovarian cancer stem cells, 40% knock-down of Bclxl expression was sufficient to induce the full activation of caspases. Bclxl expression levels in EOC cells is dynamic and can be regulated by microenvironments that are enriched with the pro-inflammatory cytokine IL-6 (Montrer IL6 Anticorps) such as the cancer stem cell and adipocyte niches.
Study reports the interaction of BCL-XL with RASSF6 (Montrer RASSF6 Anticorps). BCL-XL inhibits the interaction between RASSF6 (Montrer RASSF6 Anticorps) and MDM2 (Montrer MDM2 Anticorps) and suppresses p53 (Montrer TP53 Anticorps) expression. Consequently, BCL-XL antagonizes RASSF6 (Montrer RASSF6 Anticorps)-mediated apoptosis. Thus, the inhibition of RASSF6 (Montrer RASSF6 Anticorps)-mediated apoptosis also underlies the prosurvival role of BCL-XL.
anti-apoptotic molecules BclxL and Bcl-2 (Montrer BCL2 Anticorps) and the pro-apoptotic factors BAD and BID (Montrer BID Anticorps) cooperate to promote migration of triple-negative breast cancer cells stimulated with cl-CD95L (Montrer FASL Anticorps).
These results show that mRNA expression in centenarians is unique and reveals that Bcl-xL plays an important role in exceptional aging.
that Ubiquitin-specific peptidase 18 (Montrer USP18 Anticorps) directly bind to BCL2L1 and positively regulated its expression in hepatocellular carcinoma cells

Mouse (Murine) BCL2-Like 1 (BCL2L1) interaction partners

BCL-XL promotes stemness and contributes to the aggressiveness of both melanoma and glioblastoma.
targeting BCLxL in human and mouse synovial sarcoma with the small molecule BH3 domain inhibitor, BXI-72, achieved significant cytoreduction and increased apoptotic signaling.
GATA-3 (Montrer GATA3 Anticorps) participates in the healing of bone fractures via regulating bcl-xL gene expression, owing to its association with Runx2 (Montrer RUNX2 Anticorps).
this study demonstrates that necrosis of Mycobacterium tuberculosis-infected macrophages is dependent on the action of Bcl-xl
Mitochondrial Bcl-xL is involved in maintaining mitochondrial respiratory capacity. Its deficiency causes oxidative stress, which is associated with an increased glycolytic capacity and balanced by an increased activity of the pentose phosphate pathway.
Proapoptotic proteins BIM (Montrer BCL2L11 Anticorps) and PUMA (Montrer BBC3 Anticorps) are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL.
BMP4 (Montrer BMP4 Anticorps) promotes survival of neural stem/progenitor cells by enhancing the anti-apoptotic function of Bcl-xL via BMP4 (Montrer BMP4 Anticorps)-Smad1 (Montrer SMAD1 Anticorps)/5/8-Id1 (Montrer ID1 Anticorps) signaling in the presence of FGF-2 (Montrer FGF2 Anticorps).
We propose that the GC-induced mitochondrial accumulation of Bax (Montrer BAX Anticorps) and the interaction between the GR and Bim (Montrer BCL2L11 Anticorps), Bcl-xL and Bak (Montrer BAK1 Anticorps) could play a role in the regulation of thymocyte apoptosis.
Bcl-xL is required for survival of post mitotic neurons throughout the developing spinal cord.
anti-apoptotic molecules BclxL and Bcl-2 (Montrer BCL2 Anticorps) and the pro-apoptotic factors BAD and BID (Montrer BID Anticorps) cooperate to promote migration of triple-negative breast cancer cells stimulated with cl-CD95L (Montrer FASL Anticorps).

Cow (Bovine) BCL2-Like 1 (BCL2L1) interaction partners

amplification and characterization of partial regions of exons 2 and 3 of the bovine BCL2L1 gene
Data show that Bcl-x(L) expression is increased in the pulmonary artery undergoing chronic pulmonary vascular remodeling.

Pig (Porcine) BCL2-Like 1 (BCL2L1) interaction partners

interleukin-6 (Montrer IL6 Anticorps), endothelin ET-1 (Montrer EDN1 Anticorps), and apoptotic Bak (Montrer BAK1 Anticorps) and Bcl-XL genes have roles in small bowel transplantation, in a swine model of ischemia and reperfusion injury
Bcl-xL was significantly decreased in haploid parthenotes compared with the diploid parthenotes. These results suggest that the haploid state affects apoptosis-related gene expression which results in increased apoptosis
CONCLUSION(S): (1) Apoptosis is involved in follicular atresia; (2) Bcl-2 (Montrer BCL2 Anticorps) is induced by warm ischemia; and (3) cryopreservation insult does not alter the apoptotic signals with short tissue preparation time.
Bcl-Xl deamidation and methylation has a role in protein isoaspartate methyltransferase prevention of apoptosis induced by oxidative stress in endothelial cells
Data show that cysteine significantly reduced the expression of pro-inflammatory cytokines, including TNF-alpha (Montrer TNF Anticorps), IL-6 (Montrer IL6 Anticorps), IL-12p40, IL-1beta (Montrer IL1B Anticorps), and resulted in increased expression of the apoptosis initiator caspase-8 (Montrer CASP8 Anticorps) and bcl2L1.

Rabbit BCL2-Like 1 (BCL2L1) interaction partners

This study leads to conclude that BCLXL peak expression at the zygotic genome activation phase may be a requirement for embryo development
In this study evidence is provided that exogenous PGF2alpha differentially modulates luteal expression of BCL2L1 transcripts and protein depending on luteal stage.

Xenopus laevis BCL2-Like 1 (BCL2L1) interaction partners

repression of radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing of its expression and post-translational events that enable the protein to become effective

Zebrafish BCL2-Like 1 (BCL2L1) interaction partners

The bcl2l gene operates in the inhibition of cell death under direct regulation of a thyroid specific set of transcription factors
Zebrafish anti-apoptotic gene Bcl-xL can prevent aquatic birnavirus-induced cell death in fish cells without affecting expression of viral proteins.
transgenic overexpression of zfBLP1 or myeloid cell leukemia sequence 1a in zebrafish larvae interrupts regulation of the homeostatic balance between cell proliferation and programmed cell death during hepatogenesis and leads to liver hyperplasia
Bcl-xL can block post-apoptotic necrosis processes thereby rescuing betanodavirus-infected cells
Delta113p53 functions to antagonize p53 (Montrer TP53 Anticorps)-induced apoptosis via activating bcl2L

BCL2L1 profil antigène

Antigen Summary

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator.

Alternative names and synonyms associated with BCL2L1

BCL2 like 1 (BCL2L1) anticorps
BCL2-like 1 (Bcl2l1) anticorps
Bcl2-like 1 (Bcl2l1) anticorps
BCL2 like 1 (bcl2l1) anticorps
BCL2-like 1 L homeolog (bcl2l1.L) anticorps
BCL2 like 1 (Bcl2l1) anticorps
bcl2-like 1 (bcl2l1) anticorps

Bcl(X)L anticorps
bcl-X anticorps
bcl-x(l) anticorps
bcl-xl anticorps
bcl-xl/s anticorps
bcl-xs anticorps
bcl2l anticorps
BCL2L1 anticorps
bclx anticorps
bclxl anticorps
BCLXS anticorps
blp1 anticorps
cb1021 anticorps
PPP1R52 anticorps
xR11 anticorps
zfBLP1 anticorps

Protein level used designations for anti-BCL2-Like 1 (BCL2L1) Anticorps

apoptosis regulator Bcl-X , bcl-2-like protein 1 , protein phosphatase 1, regulatory subunit 52 , B-cell leukemia/lymphoma x , anti-apoptosis regulatory protein , bcl2-L-1 , B cell lymphoma 2 like , B cell lymphoma like X , BCL2-like protein 1 , anti-apoptotic Bcl-xL , BCLX protein , BCL2-like 1 , Bcl-X , apoptosis regulator R11 , Bcl-xL-like protein 1 , bcl-XL

GENE ID	SPECIES
598	Homo sapiens
12048	Mus musculus
24888	Rattus norvegicus
282152	Bos taurus
373954	Gallus gallus
397536	Sus scrofa
403618	Canis lupus familiaris
443061	Ovis aries
447991	Xenopus (Silurana) tropicalis
458156	Pan troglodytes
493701	Felis catus
100008875	Oryctolagus cuniculus
100224900	Taeniopygia guttata
398251	Xenopus laevis
100730495	Cavia porcellus
114401	Danio rerio

Fournisseurs de qualité sélectionnés pour anti-BCL2L1 (BCL2L1) Anticorps

Avez-vous cherché autre chose?

Tel:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@anticorps-enligne.fr

Show all anti-BCL2-Like 1 (BCL2L1) Anticorps with Pubmed References